Showing: 1 - 2 of 2 RESULTS

Medical Alley Shatters Records, Breaks $1 Billion Barrier in Three Quarters

The Medical Alley Association released their Q3 Investment Report Tuesday, revealing a record-breaking $1 billion raised in the first three quarters of 2020.

A year after raising over $1 billion in capital for the first time ever, Medical Alley companies accomplished the feat again, this time needing just three quarters to pass the $1 billion mark. In total, 58 Medical Alley companies have raised $1,015,712,605 so far this year, showing the strength of the early- and growth-stage ecosystem here and proving that 2019’s billion-dollar year was a show of ongoing growth. Digital health currently leads all sectors, having raised more than $658.6 million this year, but medical device companies are drawing substantial interest as well, with $315 million brought in so far this year.

Of the more than $1 billion raised this year, $759.3 million was raised in the third quarter alone, led by Bright Health’s $500 million Series E raise announced just eight days before the quarter’s end. Even before their exciting announcement, however, Medical Alley companies had already established a new record for funds raised in a third quarter — thanks to raises from Preventice Solutions, CVRx, and CardioMech — and had locked down the second strongest year-to-date in the last 10 years.

“During this pandemic, Medical Alley has been answering the call, delivering on our leadership position as the global epicenter of health innovation and care,” said Shaye Mandle, President and CEO of the Medical Alley Association. “Clearly, shattering another record for investment in Medical Alley health innovators demonstrates that the world increasingly looks to Medical Alley for today’s needs and to bring the future of healthcare forward.”

To see the full release and the Medical Alley Association’s analysis, visit us here.

About the Medical Alley Association

Founded in 1984, the Medical Alley Association supports and advances the global leadership of Medical Alley’s healthcare industry, and its connectivity around the world. MAA delivers the collective influence, intelligence and interactions that support Medical Alley.

View source version on


Julia Coleman
[email protected]

Source Article

Global Anti-aging Treatment Market to Surpass US$ 34.49 Billion by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global anti-aging treatment market is estimated to be valued at US$ 21.06 billion in 2020 and is expected to exhibit a CAGR of 7.3% over the forecast period (2020-2027).

Key Trends and Analysis of the Global Anti-aging Treatment Market:

Key trends in the market include increasing launches of anti-aging treatment products, increasing number of aesthetic procedures, and increasing acquisitions, partnerships, and agreements by key players. These are expected to aid in growth of the market.

According to the 2018 Plastic Surgery Statistics Report by the American Society of Plastic Surgeons, approximately 17.7 million cosmetic procedures were performed in the U.S. in 2018. According to the same source, the top three minimally invasive cosmetic procedures include botulinum toxin type A, soft tissue fillers, and chemical peel.

Moreover, key players are focusing on raising finances through investments by private equity platform in order to enhance their market presence, which is expected to drive growth of the anti-aging treatment market over the forecast period. For instance, in May 2018, Rodan + Fields, LLC, a U.S.-based skincare brand, announced that TPG Capital, an American investment company, invested in Rodan + Fields, LLC. The investment through TPG Capital will provide Rodan + Fields, LLC with an access to better business building expertise in order to expand its business domestically and internationally.

Furthermore, increasing product launches by key players is expected to propel the market growth over the forecast period. For instance, in January 2019, T.A. Sciences, a provider of clinically tested wellness products, launched T.A.-65, an anti-oxidant formula, developed for reducing the visible signs of aging, evening out discolored and blotchy skin tones, increasing skin firmness and tone, and diminishing facial wrinkles and folds.

Request Sample Copy of this Report @

Key Market Takeaways:

The global anti-aging treatment market is expected to exhibit a CAGR of 7.3% over the forecast period. This is owing to increasing number of aesthetic procedures. According to the International Society of Aesthetic Plastic Surgery, around 227,089 facial rejuvenation procedures were performed in Japan in 2017.

Among regions, North America is expected to hold dominant position in the global market over the forecast period, owing to high presence of key players such as NuFACE and Alma Laser, and rising number of minimally invasive cosmetic procedures. According to the International Society of Aesthetic Plastic Surgery, around 1,903,660 non-surgical procedures including botulinum toxin, were performed in the U.S. in 2017.

Key players operating in the global anti-aging treatment market include Allergan Plc, Estée Lauder Companies, Shiseido Company, Beiersdorf AG, L’Oréal S.A, NuFACE, Ostium Cosmetics, PhotoMedex, Inc, Alma Laser, Rodan & Fields, LLC, and others

Buy-Now this Research Report @

Market Segmentation:

  • Global Anti-aging Treatment Market, By Product Type:

  • Global Anti-aging Treatment Market, By Technology:

  • Global Anti-aging Treatment Market, By End User:

    • Hospitals

    • Skin Care Clinics

    • Homecare Settings

    • Others

  • Global Anti-aging Treatment Market, By Region:

    • North America

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Rest of Latin America

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Russia

      • Rest